Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Uterine Cervical Neoplasms 10 Neoplasms 9 Breast Neoplasms 9 Colorectal Neoplasms 8 Lung Neoplasms 5 Papillomavirus Infections 3 Uterine Cervical Dysplasia 2 Prostatic Neoplasms 2 Pancreatic Neoplasms 2 Neoplasm Metastasis 2 Heart Diseases 2 HIV Infections 2 Gastrointestinal Neoplasms 2 Esophageal Neoplasms 2 End Stage Liver Disease 2 the Rate of Participation in Screening for PBC 1 Warts 1 Venous Thromboembolism 1 Uterine Cervical Diseases 1 Urinary Bladder Neoplasms 1 Tinea 1 Squamous Intraepithelial Lesions 1 Squamous Cell Carcinoma of Head and Neck 1 Smoking 1 Skin Neoplasms 1 Retinoblastoma 1 Radiation Injuries 1 Pulmonary Atelectasis 1 Postural Orthostatic Tachycardia Syndrome 1 Postoperative Complications 1

Interventions

Blood Specimen Collection 9 Surveys and Questionnaires 6 Magnetic Resonance Spectroscopy 6 Dexamethasone 6 Cyclophosphamide 6 Prednisone 5 Mammography 5 Colonoscopy 5 Biopsy 5 Positron Emission Tomography Computed Tomography 4 Magnetic Resonance Imaging 4 Lenalidomide 4 Biopsy, Fine-Needle 4 pembrolizumab 3 Tomography, X-Ray Computed 3 Surgical Procedures, Operative 3 Melphalan 3 Liquid Biopsy 3 Interviews as Topic 3 Exercise 3 Diagnostic Tests, Routine 3 2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 3 weifuchun 2 obinutuzumab 2 fluciclovine F-18 2 daratumumab 2 carfilzomib 2 Urination 2 Preoperative Exercise 2 Positron-Emission Tomography 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Disease × Mass Screening × Clear all

NCT04590560 2024-12-09

MISS

Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS

Phase NA Recruiting

60,000 enrolled

Breast Neoplasms, Disease

Data powered by HemOnc (CC BY 4.0) Colophon ⚡